Alembic Pharmaceuticals Ltd on Monday announced that it received tentative approval for generic Ribociclib tablets used in the treatment of breast cancer in the March quarter. The tentative ...

It’s a type of targeted therapy. Kisqali comes as a tablet that you swallow. It contains the active ingredient ribociclib. Breast cancer occurs when cells in your breast grow and multiply quickly.